drugset / Trial / NCT02093728

To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

NCT02093728

Phase 1 Completed 26 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelBasic science

Summary

Study to assess the effect of Itraconazole and Fluconazole on the pharmacokinetics of Selumetinib (AZD6244; ARRY-142866) ( Hyd-Sulfate) in Healthy Male Volunteers

Timeline

Start
2014-04
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule 200 mg Oral
Subject Itraconazole Small molecule 200 mg Oral
Subject Selumetinib Small molecule 25 mg Oral

Indications